MedTrace Logo

Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation

NCT01390701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2011-07-11

No results posted yet for this study

Summary

The purpose of this study is to compare the blood pressure reducing property of transcutaneous electrical nerve stimulation with the blood pressure reducing drug felodipin.

Conditions

Interventions

DEVICE

transcutaneous electrical nerve stimulation

30 min of bi-daily low-frequency transcutaneous electrical nerve stimulation on the upper extremities. Duration: 28+-4 days.

DRUG

felodipin

2,5mg of felodipin once daily. Duration: 28+-4 days.

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Jonas Silverdal, MD · Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital/Östra

  • Karin Manhem, ass.prof. · Institute of Medicine, Department of Emergency and Cardiovascular Medicine, Sahlgrenska University Hospital/Sahlgrenska

  • Clas Mannheimer, professor · Multidisciplinary Pain Center, Sahlgrenska University Hospital/Östra

  • Georgios Mourtzinis, MD · Department of Medicine, Sahlgrenska University Hospital/Mölndal

  • Elisabet Stener-Victorin, ass.prof. · Institute of Neuroscience and Physiology, Department of Physiology, University of Gothenburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390701 on ClinicalTrials.gov